CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 3
Pages: 1  2  
Next
 

Does Neck Stage Predict Local Control After Irradiation for Head and Neck Cancer?

By

William M. Mendenhall, MD, James T. Parsons, MD, and Dietmar W. Siemann, PhD

Department of Radiation Oncology, University of Florida | March 1, 1996

The impact of neck stage (N stage) on local control after treatment for head and neck cancer is controversial. This article reviews the pertinent literature. Based on this review, the authors conclude that although N stage may be inversely related to local control, the relationship is relatively weak. Hence, current data are insufficient to justify altering treatment of the primary lesion based solely on N stage. [ONCOLOGY 10(3):381-396, 1996]

Introduction

It is important to define subsets of patients who are at high risk for recurrence after radiotherapy for head and neck cancer so that therapy may be modified in an attempt to improve the likelihood of cure. Various tumor-related parameters that correlate with the probability of local control after radiotherapy include primary tumor stage (T stage) [1,2], tumor volume [3-5] primary tumor site [2,6-10], tumor morphology (infiltrative vs exophytic), intrinsic radiosensitivity [11], and potential doubling time [12-15]. In addition, time-dose-fractionation parameters have been shown to influence tumor control rates in patients treated with radiotherapy [16-18]. Extent of tumor oxygenation [19,20] and hemoglobin level during [21] or before treatment also may be important.

In 1985, Wall et al [22] first suggested that neck stage (N stage) may be indicative of the local aggressiveness of the primary cancer, and therefore, may be yet another factor that influences local tumor control. Before that time, most practitioners believed that the likelihood of control in the neck and at the primary site were independent of each other and were related to various pathologic and clinical factors at each site, as well as the treatment administered to each site. The question is of obvious importance because if a relationship between N stage and local control does exist, it may signal a need for treatment modification (eg, altered fractionation, concurrent chemotherapy) or, in some instances, a change in therapeutic modality (eg, surgery instead of radiotherapy).

The notion that there might be a dependent relationship between local control and N stage was controversial in 1985, and this issue has not been resolved during the last 10 years. Data from various institutions on this topic are conflicting. This paper reviews the literature pertinent to this question.

Does N Stage Predict Local Control After Radiotherapy Alone?

M. D. Anderson Data

Wall et al [22] reported on a series of 248 patients with squamous cell carcinoma of the supraglottis treated with radiotherapy alone for curative intent at the M. D. Anderson Cancer Center (Houston, Texas) between 1960 and 1980. The authors grouped primary lesions according to T stage (T1 and T2 vs T3 and T4) and analyzed the influence of N stage, histologic grade, and hemoglobin levels before and during radiotherapy on the probability of local control. Neck stage was stratified into 10 groups according to the number, size, and laterality of clinically positive nodes.

Patients with T1-T2 tumors had a lower local control rate in the presence of any positive node(s), as compared with patients with a clinically negative neck (P = .06). For patients with T3-T4 cancers, a single positive node more than 3 cm in diameter did not adversely influence local control, in contrast to the presence of more advanced neck disease (P =. 03). The authors also analyzed the data using the Cox proportional hazards test and noted an inverse relationship between N stage and local control, which was pronounced for T3-T4 lesions compared to T1-T2 tumors. There was no significant relationship between local control and histologic grade or hemoglobin levels.

Patterns of Fractionation Study

Withers et al [23] analyzed 676 patients treated in nine institutions with external-beam radiotherapy alone for primary squamous cell carcinoma of the tonsillar fossa between 1976 and 1985. The nine institutions included in the patterns of fractionation study were the Princess Margaret Hospital (Toronto, Canada), Massachusetts General Hospital (Boston), M.D. Anderson Cancer Center (Houston), Christie Hospital (Manchester, United Kingdom), Clatterbridge Hospital (Liverpool, United Kingdom), University of Florida (Gainesville), Royal Marsden Hospital (London), Mount Vernon Hospital (London), and Portsmouth Hospital (Portsmouth, United Kingdom). A multivariate analysis using the Cox proportional hazards model found that T stage, N stage, total dose, and overall treatment duration significantly (P <.05) influenced local control.

University of Florida Studies

Freeman et al [2] analyzed 607 patients treated for squamous cell carcinoma of the oropharynx, hypopharynx, or supraglottic larynx with continuous-course radiotherapy alone or followed by planned neck dissection at the University of Florida between 1964 and 1988. Patients with simultaneous primary lesions were excluded. All patients were followed for at least 2 years, and no patients were lost to follow-up. Parameters tested in a multivariate analysis of local control included T stage (T1, T2, T3, and T4), N stage (N0, N1, N2A-N3A, and N2B-N3B), primary site (oropharynx, hypopharynx, and supraglottic larynx), and fractionation scheme (once- and twice-daily).

Parameters that significantly influenced local control were T stage (P < .01), fractionation (P < .01), and primary site (P = .01). Local control rates were improved after twice-daily fractionation compared with once-daily irradiation, and patients with hypopharyngeal primary lesions had lower local control rates than those with cancer in the oropharynx and supraglottic larynx. Neck stage had no apparent impact on local control (P = .97).

A separate multivariate analysis also was performed for each mucosal site, (oropharynx, hypopharynx, and supraglottic larynx). Once again, N stage did not appear to significantly influence local control in any of these subgroups.

Lee et al [7] evaluated 243 patients treated between 1964 and 1990 with external-beam irradiation alone or combined with an interstitial implant for tonsillar cancer at the University of Florida. Patients treated before 1989 were included in the analysis of Freeman et al [2]. Local control rates were examined using multivariate analysis; parameters included in the analysis were anterior extension, T stage, anterior tonsillar pillar primary, nasopharynx extension, fractionation schedule, palate extension, tongue extension, mid-line extension, brachytherapy boost, and neck stage. Anterior extension (P = .0001) and T stage (P = .0144) significantly influenced local control, whereas N stage had the least impact (P = .9415) on this end point.

Mendenhall et al [5] updated the University of Florida experience with radiotherapy alone for squamous cell carcinoma of the supraglottic larynx between 1964 and 1992. Patients treated before 1989 were included in the analysis by Freeman et al [2]. Multivariate analysis revealed the following effects on local control: T stage (P = .0001), vocal cord mobility (P = .0373), N stage (P = .0768), fractionation schedule (P = .3532), suitability for conservation surgery (P = .3532), sex (P = .5405), primary site (P = .6340), and pretreatment CT scan (P = .7299). There was a trend toward decreasing local control with increasing N stage.

French Studies

Pernot et al [8] described a series of 361 patients treated with brachytherapy alone (18 patients) or combined with external-beam radiotherapy (343 patients) for squamous cell carcinoma of the tonsillar region, soft palate, and glossotonsillar sulcus at the Centre Alexis Vautrin (Nancy, France) between 1977 and 1991. Parameters included in a multivariate analysis of local control were T stage, N stage, primary site, safety margin of the interstitial implant, overall treatment time, and interval between external-beam radiotherapy and brachytherapy.

Primary tumor stage (P = .0001), overall treatment time (P less than .0001), and primary site (P < .0001) significantly influenced local control. Patients completing treatment in less than 55 days had improved local control, as did those who had primary lesions of the tonsillar fossa, soft palate, and posterior tonsillar pillar, when compared with those with tumors of the anterior tonsillar pillar and glossotonsillar sulcus. Neck stage did not significantly affect local control.

Jaulerry et al [24] analyzed 166 patients treated with external-beam radiotherapy for squamous cell carcinoma of the base of the tongue at the Institut Curie (Paris) between 1960 and 1980. Stage of the primary tumor, regression of the primary tumor during radiotherapy, N stage (N0 vs N1 vs N2-N3), and histologic grade (well-differentiated vs moderately or poorly differentiated) were evaluated in a multivariate analysis. Primary tumor stage and regression of the primary lesion significantly influenced local control, whereas N stage and histologic grade did not.

Jaulerry et al [25] also reported on 228 patients with squamous cell carcinoma of the head and neck (oral cavity, 59 patients; oropharynx, 65 patients; hypopharynx, 37 patients; larynx, 67 patients) treated with radiotherapy alone at the Institut Curie between 1986 and 1990. Univariate analysis revealed that local control was significantly influenced by primary site (P < .009) and T stage (P< .0001) but not by N stage (P = .26). In a multivariate analysis, local control was significantly related to primary site (P = .002), T stage (P < .0001), and tumor regression at a radiation dose of 55 Gy (P = .0009).

Data from Hong Kong

Teo et al [26] evaluated 659 patients with nasopharyngeal carcinoma treated with radiotherapy at the Prince of Wales Hospital (Hong Kong) between 1984 and 1987. Multivariate analysis revealed that tumor confined to the nasopharynx was associated with improved local control, whereas cranial nerve II-VIII palsies and male gender were related to an increased risk of local recurrence. Extent of neck disease did not significantly influence local control.

Lee et al reported on 1,008 patients treated with radiotherapy alone for nasopharyngeal squamous cell carcinoma between 1976 and 1985 at the Queen Elizabeth Hospital (Hong Kong) [27]. Multivariate analysis of local control revealed the following relationships: age (P = .33), sex (P = .60), N stage (P = .5), total dose (P < .01), dose per fraction (P = .21), and overall treatment time (P = .17). Neck stage did not affect the likelihood of local failure.

Medical College of Virginia-Tufts Study

Johnson et al analyzed 76 patients treated with "concomitant boost accelerated superfractionated irradiation" for advanced squamous cell carcinoma of the head and neck at the Medical College of Virginia (Richmond) and Tufts-New England Medical Center (Boston) [28]. Tumor volume at the primary site (TV) and in the neck nodes (NV) was estimated for each patient based on pretreatment CT. Total tumor volume was defined as the sum of TV and NV. Univariate analysis of local control revealed the following: total tumor volume (P = .0001), T stage (P = .03), N stage (P = .009), sex (P = .10), age (P = .50), and primary site (P = .0004). Multivariate analysis demonstrated that total tumor volume (P = .0001), primary site ( P= .008), and sex (P = .03) significantly influenced local control, whereas T stage, N stage, stage group, and age had no statistically significant impact on this end point.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy